Abstract
Oncogenic osteomalacia, also known as tumour induced osteomalacia, is a rare paraneoplastic syndrome caused by mesenchymal tumours secreting Fibroblast Growth Factor-23 (FGF-23). The characteristic biochemical findings include hypophosphatemia and low 1,25-dihydroxy vitamin D. The differential diagnosis for hypophosphatemia are varied. We present a case of oncogenic osteomalacia in a 29-year-old female, who presented with complaints of generalized diffuse bone pain and walking difficulty for six months duration. Thus, we have discussed the approach to diagnosis in such a case.
Author supplied keywords
Cite
CITATION STYLE
Dey, B., Gochhait, D., Subramanian, H., & Ponnusamy, M. (2017). Oncogenic osteomalacia: An approach to diagnosis with a case report. Journal of Clinical and Diagnostic Research, 11(4), ED05–ED07. https://doi.org/10.7860/JCDR/2017/25055.9634
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.